Antimicrobial susceptibility and thein vitropostantibiotic effects of vancomycin and ciprofloxacin againstBacillus cereusisolates

Comparison of teicoplanin and vancomycinin vitroactivity on clinical isolates ofStaphylococcus aureus

(2012) Carlo Tascini et al.   JOURNAL OF CHEMOTHERAPY

Differential Effects of Linezolid and Ciprofloxacin on Toxin Production by Bacillus anthracis in anIn VitroPharmacodynamic System

(2011) Arnold Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Drug Interactions with Bacillus anthracis Topoisomerase IV: Biochemical Basis for Quinolone Action and Resistance

(2011) Katie J. Aldred et al.   BIOCHEMISTRY

Bacillus cereus from blood cultures: virulence genes, antimicrobial susceptibility and risk factors for blood stream infection

(2011) Toshinobu Horii et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Bacillus cereus, a Volatile Human Pathogen

(2010) E. J. Bottone   CLINICAL MICROBIOLOGY REVIEWS

Geographical distribution of genotypic and phenotypic markers among Bacillus anthracis isolates and related species by historical movement and horizontal transfer

(2009) J. L. Kiel et al.   FOLIA MICROBIOLOGICA

A patient with acute myeloid leukemia who developed fatal pneumonia caused by carbapenem-resistant Bacillus cereus

(2009) Hiroo Katsuya et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Ciprofloxacin pharmacokinetics in critically ill patients: A prospective cohort study

(2008) Arthur R.H. van Zanten et al.   JOURNAL OF CRITICAL CARE

Bacillus cereus heteroresistance to carbapenems in a cancer patient

(2008) V. Savini et al.   JOURNAL OF HOSPITAL INFECTION